Celgene

Celgene: Biotech Baron or Barren Biotech?
Seeking Alpha
Mon, 02/21/11 - 11:05 am
Celgene
Top Biotech Takeout Targets in 2011
Minyanville
Fri, 02/18/11 - 03:32 pm
M&A
biotech
Biogen Idec
Human Genome
Seattle Genetics
GSK
Dendreon
Actelion
Biomarin
Exelixis
Vertex Pharmaceuticals
Celgene
Alexion
Shire
InterMune
Lexicon Pharmaceuticals
Savient
Merck KGaA
Celgene's Management Is Creating Value
Motley Fool
Tue, 02/15/11 - 09:26 am
Celgene
Celgene: Bargain Biotech
Seeking Alpha
Sat, 02/5/11 - 10:50 am
Celgene
investors
Celgene Needs a Rocket Ship
Motley Fool
Sat, 01/29/11 - 11:51 am
Celgene
Abraxane
Merger costs weigh on Celgene's earnings
Marketwatch
Thu, 01/27/11 - 09:32 am
Celgene
earnings
M&A
companies
The Magic Formula for These Biotech Stocks
Motley Fool
Wed, 01/26/11 - 08:55 pm
biotech
Amgen
Biogen Idec
Gilead Sciences
Celgene
Why Big Pharma Is the New Big Biotech
Seeking Alpha
Fri, 01/21/11 - 07:57 am
Big Pharma
Amgen
Celgene
Gilead Sciences
Roche
Celgene's Drop Could Provide a Great Opportunity
Seeking Alpha
Tue, 01/11/11 - 12:31 pm
Celgene
earnings
Will Drug Repurposing Mean Healthy Profits?
Seeking Alpha
Mon, 01/10/11 - 07:28 pm
drug repurposing
Celgene
Merck
Pfizer
Biotech 2011 Kickoff Party: Investor Preview
TheStreet.com
Wed, 01/5/11 - 11:09 am
biotech
Celgene
Dendreon
MannKind
Vertex Pharmaceuticals
Genzyme
Ariad Pharmaceuticals
Keryx
2011 Big-Cap Biotech Preview
TheStreet.com
Wed, 12/22/10 - 09:21 am
biotech
Celgene
Amgen
Biogen Idec
Gilead Sciences
Genzyme
Sanofi
Two drugs, two price-setting tales
Fierce Pharma
Mon, 12/20/10 - 11:53 am
drug pricing
Celgene
Revlimid
Dainippon Sumitomo
Latuda
The Winner of ASH 2010: Seattle Genetics
Seeking Alpha
Mon, 12/20/10 - 09:59 am
ASH
Seattle Genetics
Celgene
GSK
Immunogen
Micromet
Novartis
Pfizer
YM BioSciences
Sanofi
Celgene Raises Price Of Blood Cancer Drug Revlimid By 4.5%
WSJ Online
Fri, 12/17/10 - 11:36 am
Revlimid
Celgene
Winners and Losers at the Hematology Society Meeting
Motley Fool
Wed, 12/8/10 - 06:54 pm
ONYX Pharmaceuticals
Seattle Genetics
Pfizer
Celgene
Immunogen
Novartis
Bristol-Myers Squibb
Takeda
JNJ
Celgene: Revlimid Cancer Risk Knocks Stock
TheStreet.com
Mon, 12/6/10 - 11:04 am
Celgene
Revlimid
Multiple Myeloma
Biotech Calendar: Key Dates for December
TheStreet.com
Tue, 11/30/10 - 09:20 am
Delcath
Arena Pharmaceuticals
RXi Pharmaceuticals
Cell Therapeutics
Amgen
Incyte
Celgene
Corcept Therapeutics
Affymax
Targacept
Exelixis
Orexigen
ONYX Pharmaceuticals
Seattle Genetics
MannKind
Alimera
AstraZeneca
Human Genome Sciences
Biotech's Biggest R&D Spenders 2010
Fierce Biotech
Mon, 11/22/10 - 10:45 am
biotech
R&D
Amgen
Biogen Idec
Gilead Sciences
Genzyme
Celgene
Kyowa Hakko Kirin
Vertex Pharmaceuticals
Life Technologies
CSL
Amylin
Genmab
Cubist Pharmaceuticals
MannKind
companies
Merial
Are These Biotechs Creating Value?
Motley Fool
Mon, 11/15/10 - 11:18 am
Seattle Genetics
Human Genome Sciences
Gilead Sciences
Celgene
biotech

Pages